VRDE whaaaaaaaaaaatttt! mention @ .05 wooooohooooo
Next Generation Viraguard(R) Reduces Threat of Disease Transmission
Highlighted by Recent Bioterrorism Concerns;
Infection Control Team Working to Find Solutions
Veridien Corporation (OTCBB:VRDE) announced today that they have
received Environmental Protection Administration (EPA) approval for
the next generation liquid disinfectant in their Viraguard(R) product
line. Viraguard(R) Hospital Disinfectant/Cleaner and Instrument
Presoak completely eradicates eight categories of bacteria, including
Staphylococcus aureus, Streptococcus pyogenes, Salmonella
choleraesuis, Pseudomonas aeruginosa, and deadly E-coli that has
caused numerous deaths associated with food contamination. EPA also
now recognizes the product as effective against mutated bacterial
strains, including Methicillin-resistant Staphylococcus aureus (MRSA)
and Vancomycin-resistant Enterococcus faecium (VRE). The EPA approval
also recognizes the ability to kill Mycobacterium tuberculosis (TB),
an encapsulated and harder to kill bacterial form. Effectiveness
against these resistant strains is of particular importance to
hospital and allied health professionals who insist on those claims
being included on any product they purchase for surface disinfection.
The EPA approval also recognizes the effectiveness of Viraguard(R) on
seven virus categories including, but not limited to, HIV, Herpes, and
Influenza, as well as effectiveness against the most common source of
fungus infection.
Sheldon Fenton, President and CEO of Veridien Corp. stated, "Our
commitment to bringing safe and effective disinfectant and
antimicrobial products to the marketplace compels us to continue our
research and development program towards finding new solutions to the
natural and man made environmental challenges we face." Mr. Fenton
continued, "With the current threat of bioterrorism, and Veridien's
decade long track record of confronting infection control challenges,
we will utilize all our expertise and resources to help safeguard
workplaces and homes."
Viraguard(R) is approved for use on hard non-porous surfaces as a
disinfectant and deodorizer for hospitals, clinics, medical offices,
nursing homes, ambulances, hotels, restaurants, schools, health spas,
and rest room facilities. Viraguard(R) leaves no harmful residue on
the surfaces that it cleans and disinfects. Residue from other
products is associated with the development of so-called "Superbugs"
that are similar to the mutated resistant strains of bacteria that
Viraguard(R) is proven to kill. The Viraguard(R) formulation is also
available in a convenient towelette canister.
Viraguard(R) is the only hard surface disinfectant formula that is
also registered with the U.S. Food and Drug Administration for use as
an antimicrobial skin cleanser, available as a liquid spray,
towelette, and clear hand gel.
Approval has also been granted by the Canadian Ministry of Health
(Health Canada) for the use of the new Viraguard(R) in institutional
medical settings and in the home as an antiseptic skin cleanser (Drug
Identification Number issued) and as hard surface disinfectant (PCP
Number issued).
Veridien has convened a panel of experts to expedite the review of
the findings and implications of ongoing tests of various Viraguard(R)
existing and developmental formulations including effectiveness
against Bacillus anthracis, the bacteria that causes Anthrax, and
against the family of bacillus associated with the transmission of
Small Pox. Veridien's infection control team is focusing on possible
solutions to deal with recent events of national concern.
About Veridien Corporation
Veridien Corporation is a Health Care Company focusing on
Infection Control and other Healthy Lifestyle products. Veridien has
developed patented and unique products including surface
disinfectants, antiseptic hand gels, a multi-use skin and surface
cleanser, contact lens care, and sun protectant products. The flagship
product Viraguard(R) Hospital Disinfectant/Cleaner and Instrument
Presoak is a patented, EPA registered, surface disinfectant,
environmentally friendly and nontoxic by OSHA Standard 29 CFR
1910.1200. Viraguard(R) Antiseptic Hand Gel is an FDA drug listed
product utilizing a patented Veridien formulation. Veridien's product
lines are currently sold internationally through a variety of
well-known distributors representing Medical, Dental, Food, Retail and
Specialty markets. Veridien's products are also available under
private label. Veridien is currently expanding sales to nationally and
regionally known retail market chains and have expanded sales through
E-Commerce.
Look for Veridien at: vrde.com; and The SunSwipe
Corporation L.L.C. at: sun-swipe.com
Special Note: Forward-looking statements in this press release are
made pursuant to the "safe-harbor" provisions of the Private
Securities Litigation Reform Act of 1995. Investors are cautioned that
such forward-looking statements involve risks and uncertainties,
including without limitation, market acceptance of, and demand for,
the Company's products, manufacturing, development and distributor
issues, product pricing, competition, technological changes and other
risks not identified herein. The Company disclaims any intent or
obligation to update any forward-looking statements.
"HEALTHY LIVING IS AN ADVENTURE - LET VERIDIEN GUIDE YOU"
--30--gaa/mi*
CONTACT: Veridien Corporation, St. Petersburg
Cheryl Ballou, 727/576-1600
Veridien@GTE.net |
